Apolipoprotein H (apoH)-dependent autoantibodies and apoH protein polymorphism in selected patients showing lupus anticoagulant activity

References

1 Lozier J, Takahashi N, Putnana FW. Complete amino acid sequence of human plasma β2-glycoprotein I. Proc Natl Acad Sci USA 1984; 81: 3640–4. 10.1073/pnas.81.12.3640Search in Google Scholar

2 Kato H, Enjoji K. Amino acid sequence and location of the disulfide bonds in bovine glycoprotein I: the presence of five sushi domains. Biochemistry 1991; 30: 11687–94. 10.1021/bi00114a012Search in Google Scholar

3 Kamboh MI, Ferrell RE, Sepehrnia B. Genetic study of human apolipoproteins. IV. Structural heterogeneity of apolipoprotein H (β2-glycoprotein I). Am J Hum Genet 1988; 42: 452–7. Search in Google Scholar

4 Sanghera DK, Kristensen T, Hamman RF, Kamboh MI. Molecular basis of the apolipoprotein H (β 2-glycoprotein I) protein polymorphism. Hum Genet 1997; 100: 57–62. 10.1007/s004390050465Search in Google Scholar

5 Cleve H, Vogt U, Kamboh MI. Genetic polymorphism of apolipoprotein H (β2-glycoprotein I) in African blacks from the Ivory Coast. Electrophoresis 1992; 13: 849–51. 10.1002/elps.11501301185Search in Google Scholar

6 Kamboh MI, Ferrell RE. Apolipoprotein H polymorphism and its role in lipid metabolism. Adv Lipid Res 1991; 1: 9–18. Search in Google Scholar

7 Hasunuma Y, Matsuura E, Makita Z, Katahira T, Nishi S, Koike T. Involvement of beta 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages. Clin Exp Immunol 1997; 107: 569–73. 10.1046/j.1365-2249.1997.d01-948.xSearch in Google Scholar

8 Schousboe I. Binding of β 2-glycoprotein I to platelets: effect of adenylate cyclase activity. Thromb Res 1980; 19: 225–37. 10.1016/0049-3848(80)90421-1Search in Google Scholar

9 Wurm H. β 2-Glycoprotein I (apolipoprotein H) interactions with phospholipid vesicles. Int J Biochem 1984; 16: 511–5. 10.1016/0020-711X(84)90168-XSearch in Google Scholar

10 Kroll J, Larsen JK, Loft H, Ezban M, Wallewick K, Faber M. DNA binding proteins in Yoshida ascites tumor fluid. Biochem Biophys Acta 1976; 434: 490–501. 10.1016/0005-2795(76)90239-7Search in Google Scholar

11 Sanghera DK, Wagenknecht DR, McIntyre JA, Kamboh MI. Identification of structural mutations in the fifth domain of apolipoprotein H ([beta] 2-glycoprotein I) which affect phospholipid binding. Hum Mol Gen 1997; 6: 311–6. 10.1093/hmg/6.2.311Search in Google Scholar PubMed

12 Kamboh MI. Genetics of apolipoprotein H (beta (2)-glycoprotein I) and anionic phospholipid binding. Lupus 1998; 7(Suppl 2): S10–3. 10.1177/096120339800700203Search in Google Scholar PubMed

13 Brighton TA, Hogg PJ, Dai YP, Murray BH, Chong BH, Chesterman CN. β2-Glycoprotein I in thrombosis: evidence for a role as a natural anticoagulant. Br J Haematol 1996; 93: 185–94. 10.1046/j.1365-2141.1996.446981.xSearch in Google Scholar

14 Giles IP, Isenberg DA, Latchman DS, Rahman A. How do antiphospholipid antibodies bind β 2-glycoprotein I?[Review] Arthritis Rheumatism 2003; 48: 2111–21. 10.1002/art.11101Search in Google Scholar

15 Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, Breda-Vriesman PJ, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335: 1544–7. 10.1016/0140-6736(90)91374-JSearch in Google Scholar

16 Reddel SW, Krilis SA. Testing for and clinical significance of anticardiolipin antibodies. Clin Diagn Lab Immunol 1999; 6: 775–82. 10.1128/CDLI.6.6.775-782.1999Search in Google Scholar PubMed PubMed Central

17 Audrain MA, El Kouri D, Hamidou MA, Mioche L, Ibara A, Langlois ML, et al. Value of autoantibodies to β 2-glycoprotein 1 in the diagnosis of antiphospholipid syndrome. Rheumatology 2002; 41: 550–3. 10.1093/rheumatology/41.5.550Search in Google Scholar PubMed

18 Hanly JG. Antiphospholipid syndrome: an overview. Can Med Assoc J 2003; 168: 1675–88. Search in Google Scholar

19 Wisløff F, Jacobsen EM, Liestøl S. Laboratory diagnosis of the antiphospholipid syndrome. Thromb Res 2003; 2121: 1–9. Search in Google Scholar

20 Alarcón-Segovia DA, Cabral AR. Clinical associations of antibodies to phospholipids and/or their protein cofactors. In: Shoenfeld Y, editor. The decade of autoimmunity. Amsterdam: Elsevier Science BV, 1999:75–9. Search in Google Scholar

21 Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a stemic review of the literature. Blood 2003; 101: 1827–32. 10.1182/blood-2002-02-0441Search in Google Scholar PubMed

22 Arnout J. Risk for thrombosis linked to the target antigen of a lupus anticoagulant? Thromb Haemost 2004; 2: 697–9. 10.1111/j.1538-7836.2004.00752.xSearch in Google Scholar PubMed

23 Takeya H, Mori, T, Gabazza EC, Kuroda K, Deguchi H, Matsuura E, et al. Anti-β2-glycoprotein I (β 2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the β 2GPI binding to phospholipids. J Clin Invest 1997; 99: 2260–8. 10.1172/JCI119401Search in Google Scholar PubMed PubMed Central

24 Galli M, Comfurius P, Barbui T, Zwaal RRA, Bevers EM. Anticoagulant activity of β2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies. Thromb Haemost 1992; 68: 297–300. 10.1055/s-0038-1656368Search in Google Scholar

25 Sheng Y, Hanly JG, Reddel SW, Kouts S, Guerin J, Koike T, et al. Detection of “antiphospholipid” antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding beta(2)-glycoprotein I and prothrombin. Clin Exp Immunol 2001; 124: 502–8. 10.1046/j.1365-2249.2001.01555.xSearch in Google Scholar PubMed PubMed Central

26 Matsuura E, Inagaki J, Kasahara H, Yamamoto D, Atsumi T, Kobayashi K, et al. Proteolytic cleavage of β2-glycoprotein I: reduction of antigenicity and the structural relationship. Int Immunol 2000; 12: 1183–92. 10.1093/intimm/12.8.1183Search in Google Scholar PubMed

27 Iverson GM, Victoria EJ, Marquis DM. Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI. Proc Natl Acad Sci USA 1998; 95: 15542–6. 10.1073/pnas.95.26.15542Search in Google Scholar PubMed PubMed Central

28 Sheng Y, Kandiah DA, Krilis SA. Anti-beta 2-glycoprotein I autoantibodies from patients with the “antiphospholipid” syndrome bind to beta-2 glycoprotein I with low affinity: dimerization of beta-2 glycoprotein I induces a significant increase in anti-beta-2 glycoprotein I antibody affinity. J Immunol 1998; 161: 2038–43. Search in Google Scholar

29 Iverson GM, Matsuura E, Victoria EJ, Cockerill KA, Linnik MD. The orientation of beta-2-GPI on the plate is important for the binding of anti-beta-2-GPI autoantibodies by ELISA. J Autoimmun 2002; 18: 289–97. 10.1006/jaut.2002.0590Search in Google Scholar PubMed

30 Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 1987; 46: 1–6. 10.1136/ard.46.1.1Search in Google Scholar PubMed PubMed Central

31 Pengo V, Brocco T, Biasiolo A, Rampazzo P, Carraro P, Zamarchi R. Procoagulant effect of anti-β2-glycoprotein I antibodies with lupus anticoagulant activity. Blood 1999; 94: 3814–9. 10.1182/blood.V94.11.3814Search in Google Scholar

32 Pengo V, Biasiolo A, Pegoraro C, Iliceto S. A two-step coagulation test to identify antiβ2-glycoprotein I lupus anticoagulants. J Thromb Haemost 2004; 5: 702–7. 10.1111/j.1538-7836.2004.00712.xSearch in Google Scholar PubMed

33 Arnout J. Risk for thrombosis linked to the target antigen of a lupus anticoagulant. J Thromb Haemost 2004; 2: 697–702. 10.1111/j.1538-7836.2004.00752.xSearch in Google Scholar PubMed

34 Ichikawa K, Khamashta MA, Koike T, Matsura E, Hughes GR. β2-Glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome. Arthritis Rheum 1994; 37: 1453–61. 10.1002/art.1780371008Search in Google Scholar PubMed

35 Arnout J, Vermylen J. Mechanism of action of β 2-glycoprotein I-dependent lupus anticoagulants. Lupus 1998; 7(Suppl 2): S23–8. 10.1177/096120339800700206Search in Google Scholar PubMed

36 Lutters BC, Meijers JC, Derksen RH, Arnout J, de Groot PG. Dimers of β 2-glycoprotein I mimic in vitro effects of β 2-glycoprotein I-anti-β 2-glycoprotein I antibody complexes. J Biol Chem 2001; 276: 3060–7. 10.1074/jbc.M008224200Search in Google Scholar PubMed

37 Gushiken FC, Le A, Arnett FC, Thiagarajan P. Polymorphisms β 2-glycoprotein I: phospholipid binding and multimeric structure. Thromb Res 2003; 108: 175–80. 10.1016/S0049-3848(02)00392-4Search in Google Scholar